NOVEL FK506-BINDING AND RAPAMYCIN-BINDING PROTEIN (FPR3 GENE-PRODUCT)IN THE YEAST SACCHAROMYCES-CEREVISIAE IS A PROLINE ROTAMASE LOCALIZEDTO THE NUCLEOLUS

Citation
Bm. Benton et al., NOVEL FK506-BINDING AND RAPAMYCIN-BINDING PROTEIN (FPR3 GENE-PRODUCT)IN THE YEAST SACCHAROMYCES-CEREVISIAE IS A PROLINE ROTAMASE LOCALIZEDTO THE NUCLEOLUS, The Journal of cell biology, 127(3), 1994, pp. 623-639
Citations number
106
Categorie Soggetti
Cytology & Histology
Journal title
ISSN journal
00219525
Volume
127
Issue
3
Year of publication
1994
Pages
623 - 639
Database
ISI
SICI code
0021-9525(1994)127:3<623:NFARP(>2.0.ZU;2-M
Abstract
The gene (FPRS) encoding a novel type of peptidylprolyl-cis-trans-isom erase (PPIase) was isolated during a search for previously unidentifie d nuclear proteins in Saccharomyces cerevisiae. PPIases are thought to act in conjunction with protein chaperones because they accelerate th e rate of conformational interconversions around proline residues in p olypeptides. The FPR3 gene product (Fpr3) is 413 amino acids long. The 111 COOH-terminal residues of Fpr3 share greater than 40% amino acid identity with a particular class of PPIases, termed FK506-binding prot eins (FKBPs) because they are the intracellular receptors for two immu nosuppressive compounds, rapamycin and FK506. When expressed in and pu rified from Escherichia coli, both full-length Fpr3 and its isolated C OOH-terminal domain exhibit readily detectable PPIase activity. Both f pr3 Delta null mutants and cells expressing FPR3 from its own promoter on a multicopy plasmid have no discernible growth phenotype and do no t display any alteration in sensitivity to the growth-inhibitory effec ts of either FK506 or rapamycin. In S. cerevisiae, the gene for a 112- residue cytosolic FKBP (FPRI) and the gene for a 135-residue ER-associ ated FKBP (FPR2) have been described before. Even fpr1 fpr2 fpr3 tripl e mutants are viable. However, in cells carrying an fpr1 Delta mutatio n (which confers resistance to rapamycin), overexpression from the GAL 1 promoter of the C-terminal domain of Fpr3, but not full-length Fpr3, restored sensitivity to rapamycin. Conversely, overproduction from th e GAL1 promoter of full-length Fpr3, but not its COOH-terminal domain, is growth inhibitory in both normal cells and fpr1 Delta mutants. In fpr1 Delta cells, the toxic effect of Fpr3 overproduction can be rever sed by rapamycin. Overproduction of the NH2-terminal domain of Fpr3 is also growth inhibitory in normal cells and fpr1 Delta mutants, but th is toxicity is not ameliorated in fpr1 Delta cells by rapamycin. The N H2-terminal domain of Fpr3 contains long stretches of acidic residues alternating with blocks of basic residues, a structure that resembles sequences found in nucleolar proteins, including S. cerevisiae NSR1 an d mammalian nucleolin. Indirect immunofluorescence with polyclonal ant ibodies raised against either the NH2- or the COOH-terminal segments o f Fpr3 expressed in E. coli demonstrated that Fpr3 is located exclusiv ely in the nucleolus.